晨光生物：与德国拜尔签订年供应量50吨供货合同不属实

Core Viewpoint - The recent rumors regarding the signing of a 50-ton supply contract with Bayer for 2025 by the company are untrue, and its industrial hemp business is still in the early stages of development, contributing less than 0.1% to the total revenue [1] Group 1 - The company clarified that the rumors about a contract with Bayer are not accurate [1] - The industrial hemp business is currently in its initial development phase [1] - Revenue from the industrial hemp segment accounts for less than 0.1% of the company's total revenue [1]